The primary antimitotic mechanism of action of the synthetic halichondrin E7389 is suppression of microtubule growth
Open Access
- 1 July 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Molecular Cancer Therapeutics
- Vol. 4 (7), 1086-1095
- https://doi.org/10.1158/1535-7163.mct-04-0345
Abstract
E7389, which is in phase I and II clinical trials, is a synthetic macrocyclic ketone analogue of the marine sponge natural product halichondrin B. Whereas its mechanism of action has not been fully elucidated, its main target seems to be tubulin and/or the microtubules responsible for the construction and proper function of the mitotic spindle. Like most microtubule-targeted antitumor drugs, it inhibits tumor cell proliferation in association with G2-M arrest. It binds to tubulin and inhibits microtubule polymerization. We examined the mechanism of action of E7389 with purified microtubules and in living cells and found that, unlike antimitotic drugs including vinblastine and paclitaxel that suppress both the shortening and growth phases of microtubule dynamic instability, E7389 seems to work by an end-poisoning mechanism that results predominantly in inhibition of microtubule growth, but not shortening, in association with sequestration of tubulin into aggregates. In living MCF7 cells at the concentration that half-maximally blocked cell proliferation and mitosis (1 nmol/L), E7389 did not affect the shortening events of microtubule dynamic instability nor the catastrophe or rescue frequencies, but it significantly suppressed the rate and extent of microtubule growth. Vinblastine, but not E7389, inhibited the dilution-induced microtubule disassembly rate. The results suggest that, at its lowest effective concentrations, E7389 may suppress mitosis by directly binding to microtubule ends as unliganded E7389 or by competition of E7389-induced tubulin aggregates with unliganded soluble tubulin for addition to growing microtubule ends. The result is formation of abnormal mitotic spindles that cannot pass the metaphase/anaphase checkpoint.Keywords
This publication has 33 references indexed in Scilit:
- Induction of Morphological and Biochemical Apoptosis following Prolonged Mitotic Blockage by Halichondrin B Macrocyclic Ketone Analog E7389Cancer Research, 2004
- The Microtubule Plus-End Proteins EB1 and Dynactin Have Differential Effects on Microtubule PolymerizationMolecular Biology of the Cell, 2003
- The Interaction of TOGp with Microtubules and TubulinOnline Journal of Public Health Informatics, 2000
- Mechanism of Action of the Unusually Potent Microtubule Inhibitor Cryptophycin 1Biochemistry, 1997
- Kinetic Stabilization of Microtubule Dynamics at Steady State by Tau and Microtubule-Binding Domains of TauBiochemistry, 1995
- Anaphase onset in vertebrate somatic cells is controlled by a checkpoint that monitors sister kinetochore attachment to the spindle.The Journal of cell biology, 1994
- Natural products which interact with tubulin in the vinca domain: Maytansine, rhizoxin, phomopsin a, dolastatins 10 and 15 and halichondrin BPharmacology & Therapeutics, 1992
- Kinetic analysis of tubulin exchange at microtubule ends at low vinblastine concentrationsBiochemistry, 1990
- Stoichiometry of the vinblastine-induced self-association of calf brain tubulinBiochemistry, 1980
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976